{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T05:27:15Z","timestamp":1738992435094,"version":"3.37.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-01861-4","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T17:40:08Z","timestamp":1738950008000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Plasma miRNAs in polycystic ovary syndrome drive endometrial cancer progression: insights into molecular pathways and therapeutic targets"],"prefix":"10.1007","volume":"16","author":[{"given":"Xuedan","family":"Lai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peihong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijiao","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianwen","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,7]]},"reference":[{"key":"1861_CR1","doi-asserted-by":"publisher","first-page":"16057","DOI":"10.1038\/nrdp.2016.57","volume":"2","author":"R Azziz","year":"2016","unstructured":"Azziz R, Carmina E, Chen Z, Dunaif A, Laven JS, Legro RS, Lizneva D, Natterson-Horowtiz B, Teede HJ, Yildiz BO. Polycystic ovary syndrome. Nat Rev Dis Primers. 2016;2:16057.","journal-title":"Nat Rev Dis Primers"},{"key":"1861_CR2","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1093\/humupd\/dmu012","volume":"20","author":"JA Barry","year":"2014","unstructured":"Barry JA, Azizia MM, Hardiman PJ. Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2014;20:748\u201358.","journal-title":"Hum Reprod Update"},{"key":"1861_CR3","doi-asserted-by":"publisher","first-page":"1166948","DOI":"10.3389\/fendo.2023.1166948","volume":"14","author":"L Thakur","year":"2023","unstructured":"Thakur L, Thakur S. The interplay of sex steroid hormones and microRNAs in endometrial cancer: current understanding and future directions. Front Endocrinol (Lausanne). 2023;14:1166948.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1861_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/cells11111836","author":"J Bloomfield","year":"2022","unstructured":"Bloomfield J, Sabbah M, Castela M, Mehats C, Uzan C, Canlorbe G. Clinical value and molecular function of circulating MicroRNAs in endometrial cancer regulation: a systematic review. Cells. 2022. https:\/\/doi.org\/10.3390\/cells11111836.","journal-title":"Cells"},{"key":"1861_CR5","doi-asserted-by":"publisher","first-page":"1027748","DOI":"10.3389\/fonc.2022.1027748","volume":"12","author":"J Lei","year":"2022","unstructured":"Lei J, Zhang G, Li D, Zhong J, Chen Q, Lin L, Liu Z. Analysis of exosomal competing endogenous RNA network response to paclitaxel treatment reveals key genes in advanced gastric cancer. Front Oncol. 2022;12:1027748.","journal-title":"Front Oncol"},{"key":"1861_CR6","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12943-019-0959-5","volume":"18","author":"X Zhang","year":"2019","unstructured":"Zhang X, Sai B, Wang F, Wang L, Wang Y, Zheng L, Li G, Tang J, Xiang J. Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT. Mol Cancer. 2019;18:40.","journal-title":"Mol Cancer"},{"key":"1861_CR7","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1016\/j.drudis.2019.06.010","volume":"24","author":"B Kulkarni","year":"2019","unstructured":"Kulkarni B, Kirave P, Gondaliya P, Jash K, Jain A, Tekade RK, Kalia K. Exosomal miRNA in chemoresistance, immune evasion, metastasis and progression of cancer. Drug Discov Today. 2019;24:2058\u201367.","journal-title":"Drug Discov Today"},{"key":"1861_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11060832","author":"R Delangle","year":"2019","unstructured":"Delangle R, De Foucher T, Larsen AK, Sabbah M, Azais H, Bendifallah S, Darai E, Ballester M, Mehats C, Uzan C, Canlorbe G. The use of microRNAs in the management of endometrial cancer: a meta-analysis. Cancers (Basel). 2019. https:\/\/doi.org\/10.3390\/cancers11060832.","journal-title":"Cancers (Basel)"},{"key":"1861_CR9","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41418-021-00838-4","volume":"29","author":"P Xue","year":"2022","unstructured":"Xue P, Huang S, Han X, Zhang C, Yang L, Xiao W, Fu J, Li H, Zhou Y. Exosomal miR-101-3p and miR-423-5p inhibit medulloblastoma tumorigenesis through targeting FOXP4 and EZH2. Cell Death Differ. 2022;29:82\u201395.","journal-title":"Cell Death Differ"},{"key":"1861_CR10","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.cell.2017.08.035","volume":"171","author":"W Ying","year":"2017","unstructured":"Ying W, Riopel M, Bandyopadhyay G, Dong Y, Birmingham A, Seo JB, Ofrecio JM, Wollam J, Hernandez-Carretero A, Fu W, Li P, Olefsky JM. Adipose tissue macrophage-derived exosomal miRNAs can modulate in vivo and in vitro insulin sensitivity. Cell. 2017;171:372-384 e12.","journal-title":"Cell"},{"key":"1861_CR11","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.fertnstert.2020.08.019","volume":"115","author":"X Jiang","year":"2021","unstructured":"Jiang X, Li J, Zhang B, Hu J, Ma J, Cui L, Chen ZJ. Differential expression profile of plasma exosomal microRNAs in women with polycystic ovary syndrome. Fertil Steril. 2021;115:782\u201392.","journal-title":"Fertil Steril"},{"key":"1861_CR12","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/ng.2764","volume":"45","author":"JN Weinstein","year":"2013","unstructured":"Weinstein JN, Collisson EA, Mills GB, Shaw KR, Ozenberger BA, Ellrott K, Shmulevich I, Sander C, Stuart JM. The cancer genome atlas pan-cancer analysis project. Nat Genet. 2013;45:1113\u201320.","journal-title":"Nat Genet"},{"key":"1861_CR13","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1093\/toxsci\/kfw058","volume":"151","author":"KN De Abrew","year":"2016","unstructured":"De Abrew KN, Kainkaryam RM, Shan YK, Overmann GJ, Settivari RS, Wang X, Xu J, Adams RL, Tiesman JP, Carney EW, Naciff JM, Daston GP. Grouping 34 chemicals based on mode of action using connectivity mapping. Toxicol Sci. 2016;151:447\u201361.","journal-title":"Toxicol Sci"},{"key":"1861_CR14","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abb0737","author":"Z Yang","year":"2021","unstructured":"Yang Z, Wang W, Zhao L, Wang X, Gimple RC, Xu L, Wang Y, Rich JN, Zhou S. Plasma cells shape the mesenchymal identity of ovarian cancers through transfer of exosome-derived microRNAs. Sci Adv. 2021. https:\/\/doi.org\/10.1126\/sciadv.abb0737.","journal-title":"Sci Adv"},{"key":"1861_CR15","volume":"5","author":"B Gyorffy","year":"2024","unstructured":"Gyorffy B. Integrated analysis of public datasets for the discovery and validation of survival-associated genes in solid tumors. Innovation (Camb). 2024;5: 100625.","journal-title":"Innovation (Camb)"},{"key":"1861_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-023-00742-4","author":"B Gyorffy","year":"2023","unstructured":"Gyorffy B. Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer. Geroscience. 2023. https:\/\/doi.org\/10.1007\/s11357-023-00742-4.","journal-title":"Geroscience"},{"key":"1861_CR17","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1186\/s12859-019-3105-x","volume":"20","author":"V Licursi","year":"2019","unstructured":"Licursi V, Conte F, Fiscon G, Paci P. MIENTURNET: an interactive web tool for microRNA-target enrichment and network-based analysis. BMC Bioinformatics. 2019;20:545.","journal-title":"BMC Bioinformatics"},{"key":"1861_CR18","first-page":"100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, Feng T, Zhou L, Tang W, Zhan L, Fu X, Liu S, Bo X, Yu G. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innovation (Camb). 2021;2:100141.","journal-title":"Innovation (Camb)"},{"key":"1861_CR19","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/1471-2105-9-559","volume":"9","author":"P Langfelder","year":"2008","unstructured":"Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinformatics. 2008;9:559.","journal-title":"BMC Bioinformatics"},{"key":"1861_CR20","doi-asserted-by":"publisher","first-page":"1070605","DOI":"10.3389\/fgene.2023.1070605","volume":"14","author":"H Ye","year":"2023","unstructured":"Ye H, Sun M, Su M, Chen D, Liu H, Ma Y, Luo W, Li H, Xu F. Identification of disease-related genes and construction of a gene co-expression database in non-alcoholic fatty liver disease. Front Genet. 2023;14:1070605.","journal-title":"Front Genet"},{"key":"1861_CR21","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.34408","author":"G Hemani","year":"2018","unstructured":"Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, Laurin C, Burgess S, Bowden J, Langdon R, Tan VY, Yarmolinsky J, Shihab HA, Timpson NJ, Evans DM, Relton C, Martin RM, Davey Smith G, Gaunt TR, Haycock PC. The MR-Base platform supports systematic causal inference across the human phenome. Elife. 2018. https:\/\/doi.org\/10.7554\/eLife.34408.","journal-title":"Elife"},{"key":"1861_CR22","doi-asserted-by":"publisher","first-page":"1007081","DOI":"10.1371\/journal.pgen.1007081","volume":"13","author":"G Hemani","year":"2017","unstructured":"Hemani G, Tilling K, Davey Smith G. Orienting the causal relationship between imprecisely measured traits using GWAS summary data. PLoS Genet. 2017;13:1007081.","journal-title":"PLoS Genet"},{"key":"1861_CR23","doi-asserted-by":"publisher","first-page":"5482","DOI":"10.1016\/j.cell.2021.09.014","volume":"184","author":"BA Luca","year":"2021","unstructured":"Luca BA, Steen CB, Matusiak M, Azizi A, Varma S, Zhu C, Przybyl J, Espin-Perez A, Diehn M, Alizadeh AA, van de Rijn M, Gentles AJ, Newman AM. Atlas of clinically distinct cell states and ecosystems across human solid tumors. Cell. 2021;184:5482-5496 e28.","journal-title":"Cell"},{"key":"1861_CR24","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1016\/j.ccell.2021.08.011","volume":"39","author":"CB Steen","year":"2021","unstructured":"Steen CB, Luca BA, Esfahani MS, Azizi A, Sworder BJ, Nabet BY, Kurtz DM, Liu CL, Khameneh F, Advani RH, Natkunam Y, Myklebust JH, Diehn M, Gentles AJ, Newman AM, Alizadeh AA. The landscape of tumor cell states and ecosystems in diffuse large B cell lymphoma. Cancer Cell. 2021;39:1422-1437 e10.","journal-title":"Cancer Cell"},{"key":"1861_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/cpz1.90","volume":"1","author":"Z Xie","year":"2021","unstructured":"Xie Z, Bailey A, Kuleshov MV, Clarke DJB, Evangelista JE, Jenkins SL, Lachmann A, Wojciechowicz ML, Kropiwnicki E, Jagodnik KM, Jeon M, Ma\u2019ayan A. Gene set knowledge discovery with enrichr. Curr Protoc. 2021;1: e90.","journal-title":"Curr Protoc"},{"key":"1861_CR26","doi-asserted-by":"publisher","first-page":"3069","DOI":"10.1093\/bioinformatics\/btv313","volume":"31","author":"M Yoo","year":"2015","unstructured":"Yoo M, Shin J, Kim J, Ryall KA, Lee K, Lee S, Jeon M, Kang J, Tan AC. DSigDB: drug signatures database for gene set analysis. Bioinformatics. 2015;31:3069\u201371.","journal-title":"Bioinformatics"},{"key":"1861_CR27","first-page":"266","volume":"20","author":"H Du","year":"2020","unstructured":"Du H, He Z, Feng F, Chen D, Zhang L, Bai J, Wu H, Han E, Zhang J. Hsa_circ_0038646 promotes cell proliferation and migration in colorectal cancer via miR-331-3p\/GRIK3. Oncol Lett. 2020;20:266\u201374.","journal-title":"Oncol Lett"},{"key":"1861_CR28","doi-asserted-by":"publisher","first-page":"9611","DOI":"10.2147\/OTT.S266541","volume":"13","author":"S Li","year":"2020","unstructured":"Li S, Wu Y, Zhang J, Sun H, Wang X. Role of miRNA-424 in Cancers. Onco Targets Ther. 2020;13:9611\u201322.","journal-title":"Onco Targets Ther"},{"key":"1861_CR29","doi-asserted-by":"publisher","first-page":"19287","DOI":"10.1038\/s41598-023-45317-7","volume":"13","author":"M Niemira","year":"2023","unstructured":"Niemira M, Erol A, Bielska A, Zeller A, Skwarska A, Chwialkowska K, Kuzmicki M, Szamatowicz J, Reszec J, Knapp P, Moniuszko M, Kretowski A. Identification of serum miR-1246 and miR-150-5p as novel diagnostic biomarkers for high-grade serous ovarian cancer. Sci Rep. 2023;13:19287.","journal-title":"Sci Rep"},{"key":"1861_CR30","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.ncrna.2024.01.002","volume":"9","author":"R Heidarzadehpilehrood","year":"2024","unstructured":"Heidarzadehpilehrood R, Pirhoushiaran M. Biomarker potential of competing endogenous RNA networks in Polycystic Ovary Syndrome (PCOS). Noncoding RNA Res. 2024;9:624\u201340.","journal-title":"Noncoding RNA Res"},{"key":"1861_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112600","volume":"146","author":"A Jafarzadeh","year":"2022","unstructured":"Jafarzadeh A, Paknahad MH, Nemati M, Jafarzadeh S, Mahjoubin-Tehran M, Rajabi A, Shojaie L, Mirzaei H. Dysregulated expression and functions of microRNA-330 in cancers: a potential therapeutic target. Biomed Pharmacother. 2022;146: 112600.","journal-title":"Biomed Pharmacother"},{"key":"1861_CR32","first-page":"1584","volume":"23","author":"HL Zhang","year":"2019","unstructured":"Zhang HL, Wang XX, Zhang F. Correlations of the MiR-330 expression with the pathogenesis and prognosis of breast cancer. Eur Rev Med Pharmacol Sci. 2019;23:1584\u201390.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1861_CR33","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41598-020-57838-6","volume":"10","author":"S Pfeiffer","year":"2020","unstructured":"Pfeiffer S, Sanchez-Lechuga B, Donovan P, Halang L, Prehn JHM, Campos-Caro A, Byrne MM, Lopez-Tinoco C. Circulating miR-330-3p in late pregnancy is associated with pregnancy outcomes among lean women with GDM. Sci Rep. 2020;10:908.","journal-title":"Sci Rep"},{"key":"1861_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0206239","volume":"13","author":"C Sticht","year":"2018","unstructured":"Sticht C, De La Torre C, Parveen A, Gretz N. miRWalk: An online resource for prediction of microRNA binding sites. PLoS ONE. 2018;13: e0206239.","journal-title":"PLoS ONE"},{"key":"1861_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2024.111286","volume":"184","author":"M Kumar","year":"2024","unstructured":"Kumar M. Hypothesis: androgen receptor\/Aurora A kinase\/NF-\u03baB signaling axis induce inflammatory response during polycystic ovarian syndrome progression. Med Hypotheses. 2024;184: 111286.","journal-title":"Med Hypotheses"},{"key":"1861_CR36","doi-asserted-by":"publisher","first-page":"3873","DOI":"10.1073\/pnas.1806862116","volume":"116","author":"M Kriseman","year":"2019","unstructured":"Kriseman M, Monsivais D, Agno J, Masand RP, Creighton CJ, Matzuk MM. Uterine double-conditional inactivation of Smad2 and Smad3 in mice causes endometrial dysregulation, infertility, and uterine cancer. Proc Natl Acad Sci U S A. 2019;116:3873\u201382.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1861_CR37","doi-asserted-by":"publisher","first-page":"3883","DOI":"10.1073\/pnas.1806838116","volume":"116","author":"D Monsivais","year":"2019","unstructured":"Monsivais D, Peng J, Kang Y, Matzuk MM. Activin-like kinase 5 (ALK5) inactivation in the mouse uterus results in metastatic endometrial carcinoma. Proc Natl Acad Sci U S A. 2019;116:3883\u201392.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1861_CR38","doi-asserted-by":"publisher","first-page":"e139985","DOI":"10.5812\/ijpr-139985","volume":"22","author":"R Heidarzadehpilehrood","year":"2023","unstructured":"Heidarzadehpilehrood R, Pirhoushiaran M, Binti Osman M, Ling KH, Abdul Hamid H. Unveiling key biomarkers and therapeutic drugs in polycystic ovary syndrome (PCOS) through pathway enrichment analysis and hub gene-miRNA networks. Iran J Pharm Res. 2023;22:e139985.","journal-title":"Iran J Pharm Res"},{"key":"1861_CR39","first-page":"881","volume":"62","author":"D Dai","year":"2002","unstructured":"Dai D, Wolf DM, Litman ES, White MJ, Leslie KK. Progesterone inhibits human endometrial cancer cell growth and invasiveness: down-regulation of cellular adhesion molecules through progesterone B receptors. Cancer Res. 2002;62:881\u20136.","journal-title":"Cancer Res"},{"key":"1861_CR40","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1210\/er.2012-1043","volume":"34","author":"JJ Kim","year":"2013","unstructured":"Kim JJ, Kurita T, Bulun SE. Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer. Endocr Rev. 2013;34:130\u201362.","journal-title":"Endocr Rev"},{"key":"1861_CR41","doi-asserted-by":"publisher","first-page":"106590","DOI":"10.1016\/j.isci.2023.106590","volume":"26","author":"X Wang","year":"2023","unstructured":"Wang X, Kho PF, Ramachandran D, Bafligil C, Amant F, Goode EL, Scott RJ, Tomlinson I, Evans DG, Crosbie EJ, Dork T, Spurdle AB, Glubb DM, O\u2019Mara TA. Multi-trait genome-wide association study identifies a novel endometrial cancer risk locus that associates with testosterone levels. iScience. 2023;26:106590.","journal-title":"iScience"},{"key":"1861_CR42","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1530\/JME-10-0064","volume":"46","author":"YH Cheng","year":"2011","unstructured":"Cheng YH, Utsunomiya H, Pavone ME, Yin P, Bulun SE. Retinoic acid inhibits endometrial cancer cell growth via multiple genomic mechanisms. J Mol Endocrinol. 2011;46:139\u201353.","journal-title":"J Mol Endocrinol"},{"key":"1861_CR43","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.ctrv.2007.11.003","volume":"34","author":"A Duenas-Gonzalez","year":"2008","unstructured":"Duenas-Gonzalez A, Candelaria M, Perez-Plascencia C, Perez-Cardenas E, de la Cruz-Hernandez E, Herrera LA. Valproic acid as epigenetic cancer drug: preclinical, clinical and transcriptional effects on solid tumors. Cancer Treat Rev. 2008;34:206\u201322.","journal-title":"Cancer Treat Rev"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-01861-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-01861-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-01861-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T17:40:12Z","timestamp":1738950012000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-01861-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,7]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1861"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-01861-4","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,7]]},"assertion":[{"value":"2 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"133"}}